tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX

Moleculin Biotech (MBRX) Ownership - Who Owns Moleculin Biotech?

1,312 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 27, 2023Bought$10000
Dec 27, 2023
Walter V Klemp
Ceo & President,director
Bought$129999
Dec 27, 2023Bought$20000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,070,813Institution48.07%4,843,287
222,177Institution9.97%1,004,907
74,679Institution3.35%337,773
5,479Institution0.25%24,782
3,182Institution0.14%14,392
1,608Institution0.07%7,273

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,070,813Institution48.07%4,843,287
222,177Institution9.97%1,004,907
5,479Institution0.25%24,782
3,182Institution0.14%14,392
1,608Institution0.07%7,273

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
44,365Institution1.99%262,197
30,314Institution1.36%179,156

FAQ

Who Owns Moleculin Biotech (MBRX)?
Currently, no data Available
What percentage of Moleculin Biotech (MBRX) stock is held by institutional investors?
Currently, no data Available
What percentage of Moleculin Biotech (MBRX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Moleculin Biotech (MBRX)?
VANGUARD INDEX FUNDS owns the most shares of Moleculin Biotech (MBRX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis